精神分裂症背外侧前额叶皮质谷氨酸脱羧酶转录本改变的定位与诊断特异性
该研究在精神分裂症、重性抑郁、双相障碍及未患病对照的DLPFC浅层和深层定量GAD67与GAD65 mRNA。结果显示精神分裂症组浅层GAD67和GAD65 mRNA均降低,重性抑郁组仅浅层GAD67降低且未达显著,双相障碍组无差异。
要点
- 精神分裂症DLPFC浅层GAD67和GAD65 mRNA降低,深层无改变。
- 重性抑郁仅浅层GAD67 mRNA降低,p=.089未达显著。
- 双相障碍组未检测到GAD67或GAD65 mRNA差异。
核心结论
- GABA合成标志物改变具有转录本、DLPFC分层和诊断特异性。
- 浅层DLPFC的GABA合成受限可能贡献精神分裂症工作记忆损害。
研究设计与样本
- 采用定量聚合酶链反应定量DLPFC浅层与深层的GAD67和GAD65 mRNA。
- 纳入精神分裂症41例、重性抑郁42例、双相障碍39例及未患病对照43例。
主要发现
- 精神分裂症组浅层GAD67 mRNA低于对照组(p=.039,效应量=-0.69)。
- 精神分裂症组浅层GAD65 mRNA低于对照组(p=.027,效应量=-0.72)。
- 精神分裂症组深层GAD67和GAD65 mRNA无改变。
- 重性抑郁组仅浅层GAD67 mRNA降低(p=.089,效应量=0.70)。
- 双相障碍组未检测到GAD67或GAD65 mRNA差异。
关键数值与推荐
- 精神分裂症浅层GAD67 mRNA组间比较p=.039,效应量=-0.69。
- 精神分裂症浅层GAD65 mRNA组间比较p=.027,效应量=-0.72。
- 重性抑郁浅层GAD67 mRNA组间比较p=.089,效应量=0.70。
临床怎么用
- 支持精神分裂症工作记忆损害与DLPFC浅层GABA合成受限相关的假说。
- 提示高工作记忆需求任务中GAD67和GAD65共同活动可能更为关键。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Working memory (WM) deficits in schizophrenia are thought to reflect altered inhibition in the dorsolateral prefrontal cortex (DLPFC). This interpretation is supported by findings of lower transcript levels of the 2 enzymes, GAD67 and GAD65, which mediate basal and activity-dependent GABA (gamma-aminobutyric acid) synthesis, respectively. However, the relative magnitude, location within the depth of the DLPFC, and specificity to the disease process of schizophrenia of alterations in GAD67 and/or GAD65 remain unclear. METHODS: Levels of GAD67 and GAD65 messenger RNAs (mRNAs) in superficial (layers 2/superficial 3) and deep (deep layer 6/white matter) zones of the DLPFC were quantified by quantitative polymerase chain reaction in subjects with schizophrenia (n = 41), major depression (n = 42), or bipolar disorder (n = 39) and unaffected comparison (n = 43) subjects. RESULTS: Relative to the unaffected comparison group, GAD67 and GAD65 mRNA levels in the schizophrenia group were lower (p = .039, effect size = -0.69 and p = .027, effect size = -0.72, respectively) in the superficial zone but were unaltered in the deep zone. In the major depression group, only GAD67 mRNA levels were lower and only in the superficial zone (p = .089, effect size = 0.70). No differences were detected in the bipolar disorder group. Neither GAD67 nor GAD65 mRNA alterations were explained by psychosis, mood disturbance, or common comorbid factors. CONCLUSIONS: Alterations in markers of GABA synthesis demonstrated transcript, DLPFC zone, and diagnostic specificity. Given the dependence of WM on GABA neurotransmission in the superficial DLPFC, our findings suggest that limitations to GABA synthesis in this location contribute to WM impairments in schizophrenia, especially during demanding WM tasks, when GABA synthesis requires the activity of both GAD67 and GAD65.
引用
- Dowling KF, Dienel SJ, Barile Z, et al. Localization and Diagnostic Specificity of Glutamic Acid Decarboxylase Transcript Alterations in the Dorsolateral Prefrontal Cortex in Schizophrenia. Biol Psychiatry. 2023. PMID: 37061080. doi:10.1016/j.biopsych.2023.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。